Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR7280 vs Ganirelix in Women Undergoing COH for IVF/ICSI
NCT05994378Phase 3Completed
- Sponsor
- Hengrui
- Start
- Aug 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of SHR7280 in female infertility, sponsored by Hengrui. Started Aug 2023; status: completed.
02
Drugs
SHR7280
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT05994378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05994378.